Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
GTC Biotherapeutics Inc (GTCB) $1.06 0.01 (0.93%) as of 4:30 Mon 2/8 Download
   
Exchange: Nasdaq Small Cap
Security Type: Common
Shares Out: 10,436,000 as of 3/29
Market Cap: 11.06(M)
Last Volume: 4,325 Avg Vol: 52,622
52 Week Range: $0.63 - $6.3
Level I Sector: Health Care
Level II Sector:   Drugs
Level III Sector:      Biotechnology
Member Indexes:
    NASDAQ COMPOSITE       NASDAQ NNM COMPOSITE  
Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

  6 Months   1 Year   2 Year  

Company Profile   GTC Biotherapeutics develops and produces human therapeutic proteins through transgenic technology that provides production of therapeutic proteins in the milk of transgenic mammals. As of Dec 31 2006, Co.'s proprietary products and product candidates in development includes ATryn? which is a recombinant form of human antithrombin; rhFVIIa which is a blood coagulation factor; rhAAT which is an inhibitor of elastase; and CD137 which is involved in the initiation and regulation of the human immune system. In addition, Co. has external program under contract with Merrimack Pharmaceuticals, Inc., for transgenic production and purification of Merrimack's recombinant human alpha-fetoprotein.

Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 3,387,851 3,387,851 7,611,059
Total Buy Value $0 $3,625,001 $3,625,001 $7,198,901
Total People Bought 0 1 1 3
Total Buy Transactions 0 1 1 5
Total Shares Sold 0 0 0 39,930
Total Sell Value $0 $0 $0 $22,625
Total People Sold 0 0 0 2
Total Sell Transactions 0 0 0 2
End Date 2009-11-08 2009-08-07 2009-02-06 2008-02-07

   
Records found: 228
  Page 1 of 10  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Lfb Biotechnologies S.a.s.u. Director by Deputization   –       •       •   2010-01-06 4 OE $2.24 $12,749,996 D/D 5,299,071 21,299,906     -
   Mcnamara Pamela W Director   –       •      –    2009-12-31 4 A $0.75 $1,000 D/D 1,333 4,502     -
   Bullock Francis J Director   –       •      –    2009-12-31 4 A $0.75 $1,875 D/D 2,500 7,882     -
   Tuck Alan W Director   –       •      –    2009-12-31 4 A $0.75 $1,500 D/D 2,000 6,121     -
   Geraghty James A Director   –       •      –    2009-12-31 4 A $0.75 $3,000 D/D 4,000 19,025     -
   Green John B Senior VP and CFO   •       –      –    2009-11-02 4 A $1.21 $16,604 D/D 13,722 28,173     -
   Cox Geoffrey F President, CEO and Chairman   •       •      –    2009-11-02 4 A $1.21 $38,267 D/D 31,626 87,944     -
   Lfb Biotechnologies S.a.s.u. Director by Deputization   –       •       •   2009-11-02 4 B $1.07 $3,625,001 D/D 3,387,851 16,000,835 3.92 -12%     
   Scotland Richard A Senior VP, Regulatory Affairs   •       –      –    2009-11-02 4 A $1.21 $13,634 D/D 11,268 21,899     -
   Meade Harry SVP, Transgenic Research   •       –      –    2009-11-02 4 A $1.21 $16,454 D/D 13,598 29,452     -
   Woloshen Daniel S Senior VP and General Counsel   •       –      –    2009-11-02 4 A $1.21 $14,178 D/D 11,717 22,033     -
   Woloshen Daniel S Senior VP and General Counsel   •       –      –    2009-11-02 4/A D $1.21 $5,066 D/D (4,187) 19,215     -
   Meade Harry SVP, Transgenic Research   •       –      –    2009-11-02 4/A A $1.21 $18,638 D/D 15,403 31,257     -
   Meade Harry SVP, Transgenic Research   •       –      –    2009-11-02 4/A D $1.21 $6,679 D/D (5,520) 25,737     -
   Woloshen Daniel S Senior VP and General Counsel   •       –      –    2009-11-02 4/A A $1.21 $15,834 D/D 13,086 23,402     -
   Scotland Richard A Senior VP, Regulatory Affairs   •       –      –    2009-11-02 4/A D $1.21 $7,754 D/D (6,408) 17,587     -
   Scotland Richard A Senior VP, Regulatory Affairs   •       –      –    2009-11-02 4/A A $1.21 $16,170 D/D 13,364 23,995     -
   Green John B Senior VP and CFO   •       –      –    2009-11-02 4/A D $1.21 $6,760 D/D (5,587) 24,413     -
   Green John B Senior VP and CFO   •       –      –    2009-11-02 4/A A $1.21 $18,814 D/D 15,549 30,000     -
   Cox Geoffrey F President, CEO and Chairman   •       •      –    2009-11-02 4/A D $1.21 $13,544 D/D (11,193) 80,411     -
   Cox Geoffrey F President, CEO and Chairman   •       •      –    2009-11-02 4/A A $1.21 $42,696 D/D 35,286 91,604     -
   Lfb Biotechnologies S.a.s.u. Director by Deputization   –       •       •   2009-10-30 4 OE $2.24 $25,499,997 D/D 10,598,144 12,612,984     -
   Nguyen Evelyne Director   –       •      –    2009-10-01 3 $0.00 $0 D/D 0 133     -
   Tuck Alan W Director   –       •      –    2009-09-25 4 A $1.76 $1,500 D/D 853 4,121     -
   Bullock Francis J Director   –       •      –    2009-09-25 4 A $1.76 $1,876 D/D 1,067 5,382     -
  228 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 10
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2009 J3SG.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us